| Literature DB >> 27287764 |
A A El Kholy1, N A Mostafa2, A A Ali3, M M S Soliman1, S A El-Sherbini2, R I Ismail2, N El Basha2, R I Magdy2, N El Rifai2, D H Hamed2.
Abstract
Respiratory tract infection is a major cause of hospitalization in children. Although most such infections are viral in origin, it is difficult to differentiate bacterial and viral infections, as the clinical symptoms are similar. Multiplex polymerase chain reaction (PCR) methods allow testing for multiple pathogens simultaneously and are, therefore, gaining interest. This prospective case-control study was conducted from October 2013 to February 2014. Nasopharyngeal (NP) and oropharyngeal (throat) swabs were obtained from children admitted with severe acute respiratory infection (SARI) at a tertiary hospital. A control group of 40 asymptomatic children was included. Testing for 16 viruses was done by real-time multiplex PCR. Multiplex PCR detected a viral pathogen in 159/177 (89.9 %) patients admitted with SARI. There was a high rate of co-infection (46.9 %). Dual detections were observed in 64 (36.2 %), triple detections in 17 (9.6 %), and quadruple detections in 2 (1.1 %) of 177 samples. Seventy-eight patients required intensive care unit (ICU) admission, of whom 28 (35.8 %) had co-infection with multiple viruses. AdV, HBoV, HRV, HEV, and HCoV-OC43 were also detected among asymptomatic children. This study confirms the high rate of detection of viral nucleic acids by multiplex PCR among hospitalized children admitted with SARI, as well as the high rate of co-detection of multiple viruses. AdV, HBoV, HRV, HEV, and HCoV-OC43 were also detected in asymptomatic children, resulting in challenges in clinical interpretation. Studies are required to provide quantitative conclusions that will facilitate clinical interpretation and application of the results in the clinical setting.Entities:
Mesh:
Year: 2016 PMID: 27287764 PMCID: PMC7088036 DOI: 10.1007/s10096-016-2698-5
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267
The demographic and clinical characteristics of the patients
| Variable | |
|---|---|
| Age, months (median, range) | 4 (1–35) |
| Duration of hospital stay, days (median, range) | 5 (1–33) |
| Temperature, °C (median, range) | 38.0 (36.0–40.5) |
| Median interval between onset of symptoms and hospital admission, days (median, range) | 3 (1–26) |
| Respiratory rate, breaths/min (median, range) | 50 (30–80) |
| Gender, | |
| Male | 94 (53.4) |
| Female | 82 (46.6) |
| Clinical manifestations | |
| Tachypnea, | 151 (85.3) |
| Chest indrawing, | 134 (75.7) |
| Wheezing, | 108 (61.0) |
| Grunting, | 64 (36.2) |
| Refusal of feeding, | 43 (24.3) |
| Lethargy, | 36 (20.3) |
| Vomiting, | 31 (17.5) |
| Nasal flaring, | 23 (13) |
| Convulsions, | 2 (1.1) |
| Stridor, | 1 (0.6) |
| Underlying chronic illness, | 58 (32.8) |
| Chest X-ray findings (total = 85), | |
| Consolidate | 46 (54.1) |
| Bronchopneumonia patches | 20 (23.5) |
| Infiltrate | 15 (17.6) |
| Hyperinflation | 13 (15.3) |
| Lung collapse | 2 (2.4) |
| Effusion | 1 (1.7) |
| Oxygen therapy, | 107 (60.5) |
| Duration of oxygen therapy, days (median, range) | 4 (1–15) |
| ICU admission, | 78 (44.1) |
| Duration of ICU admission, days (median, range) | 8 (2–41) |
| Mechanical ventilation, | 35 (19.8) |
| Duration of mechanical ventilation, days (median, range) | 7 (1–36) |
| Antibiotic therapy during hospital admission, | 169 (95.5) |
| WBC count, cells/mm3 (mean, SD) | 13,495.83 (8253.15) |
| Outcome, | |
| Discharge | 106 (59.9) |
| Death | 16 (9.0) |
| Transfer | 55 (31.1) |
The frequency distribution of the pathogens among the patients
| Pathogen | Frequency, | Single detection ( | Co-detection ( |
|---|---|---|---|
| RSV | 85 (48) | 40 | 45 |
| HRV | 78 (44.1) | 14 | 64 |
| AdV | 31 (17.5) | 3 | 28 |
| HBoV | 16 (9) | 3 | 13 |
| Flu A | 11 (6.2) | 5 | 6 |
| hMPV | 9 (5.1) | 3 | 6 |
| HEV | 8 (4.5) | 0 | 8 |
| PIV-4 | 6 (3.4) | 1 | 5 |
| PIV-3 | 5 (2.8) | 2 | 3 |
| Flu B | 4 (2.3) | 2 | 2 |
| HCoV-NL63 | 4 (2.3) | 2 | 2 |
| PIV-1 | 2 (1.1) | 0 | 2 |
| HCoV-OC43 | 2 (1.1) | 0 | 2 |
| PIV-2 | 1 (0.6) | 0 | 1 |
| HCoV-229E | 1 (0.6) | 1 | 0 |
RSV, respiratory syncytial virus; HRV, human rhinovirus; AdV, adenovirus; HBoV, human bocavirus; Flu A, B, influenza virus group A, group B; hMPV, human metapneumovirus; HEV, human enterovirus; PIV-1, -2, -3, -4, parainfluenza virus type 1, 2, 3, 4; HCoV, human coronavirus
Fig. 1Monthly distribution of the detected viruses among the patients
Frequency of pathogen detection among the control group
| Pathogen | Frequency ( |
|---|---|
| None | 12 |
| AdV | 14 |
| HBoV | 12 |
| HEV | 6 |
| HCoV-OC43 | 6 |
| HRV | 4 |
| Mixed | 10 |
AdV, adenovirus; HBoV, human bocavirus; HEV, human enterovirus; HCoV-OC43, human coronavirus OC43; HRV, human rhinovirus
Fig. 2Comparison of the frequency of the viruses detected in patients and controls